A Study to Evaluate the Performance and Potential Benefits of an Assistive Artificial Intelligence Device ScanNav Anatomy Peripheral Nerve Block - US V1.0 for Ultrasound-guided Regional Anesthesia

ClinicalTrials.gov ID: NCT04918693

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04918693. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 12:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a single-center, prospective study to be undertaken at University of Oregon, Portland, USA. The aim is to provide data on the clinical performance of ScanNav Anatomy PNB for identification of anatomical structures during UGRA scanning, in particular: 1. Assess the benefits of the device to intended users when supervising a trainee who is performing UGRA scanning. 2. Assess the benefits of the device when intended users perform UGRA scanning. 3. Assess risk mitigation by the intended users when performing UGRA scanning.

Study identification

NCT ID: NCT04918693
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: IntelligentUltrasound Limited; Industry
Enrollment: 34 participants

Conditions and interventions

Conditions

Ultrasound Imaging of Anatomical Structures

Interventions

Ultrasound scanning Device

Device

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 16, 2021 (Actual)
Primary completion: May 22, 2021 (Actual)
Completion: Nov 30, 2021 (Actual)
Last update posted: Apr 1, 2022

2021

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Oregon Health & Science University	Portland	Oregon	97239	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04918693, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 1, 2022 · Synced Nov 13, 2026